RBOT vs. LFWD, MLSS, COCH, NTRB, CLGN, INGN, MOVE, LEXX, NXTC, and SNSE
Should you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include ReWalk Robotics (LFWD), Milestone Scientific (MLSS), Envoy Medical (COCH), Nutriband (NTRB), CollPlant Biotechnologies (CLGN), Inogen (INGN), Movano (MOVE), Lexaria Bioscience (LEXX), NextCure (NXTC), and Sensei Biotherapeutics (SNSE). These companies are all part of the "medical" sector.
ReWalk Robotics (NASDAQ:LFWD) and Vicarious Surgical (NYSE:RBOT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, community ranking, dividends, media sentiment, valuation, profitability, institutional ownership, risk and analyst recommendations.
26.8% of ReWalk Robotics shares are held by institutional investors. Comparatively, 47.3% of Vicarious Surgical shares are held by institutional investors. 2.1% of ReWalk Robotics shares are held by insiders. Comparatively, 11.7% of Vicarious Surgical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Vicarious Surgical received 6 more outperform votes than ReWalk Robotics when rated by MarketBeat users. However, 100.00% of users gave ReWalk Robotics an outperform vote while only 38.10% of users gave Vicarious Surgical an outperform vote.
Vicarious Surgical has a net margin of 0.00% compared to Vicarious Surgical's net margin of -159.76%. Vicarious Surgical's return on equity of -28.19% beat ReWalk Robotics' return on equity.
ReWalk Robotics has higher revenue and earnings than Vicarious Surgical. ReWalk Robotics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks.
In the previous week, ReWalk Robotics had 2 more articles in the media than Vicarious Surgical. MarketBeat recorded 4 mentions for ReWalk Robotics and 2 mentions for Vicarious Surgical. ReWalk Robotics' average media sentiment score of 0.53 beat Vicarious Surgical's score of -0.03 indicating that Vicarious Surgical is being referred to more favorably in the news media.
ReWalk Robotics has a beta of 2.06, meaning that its stock price is 106% more volatile than the S&P 500. Comparatively, Vicarious Surgical has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500.
ReWalk Robotics currently has a consensus target price of $9.00, suggesting a potential upside of 81.09%. Vicarious Surgical has a consensus target price of $0.67, suggesting a potential upside of 116.38%. Given ReWalk Robotics' higher possible upside, analysts plainly believe Vicarious Surgical is more favorable than ReWalk Robotics.
Summary
ReWalk Robotics beats Vicarious Surgical on 9 of the 17 factors compared between the two stocks.
Get Vicarious Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Vicarious Surgical Competitors List
Related Companies and Tools
